A composition for improving egg collection effect and its preparation method and application
Through the composition of sodium selenite, vitamin E, arginine hydrochloride and triethyl citrate, the problems of low efficiency and high sensitivity in live egg collection-in vitro embryo production of dairy cows are solved, and oocytes are improved Quantity and blastocyst formation rate enable more efficient in vitro embryo production.
Patent Information
- Application Number
- CN202311166828.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-09-11
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2043-09-11
AI Technical Summary
In the in vivo egg collection-in vitro embryo production technology, the in vitro embryo production efficiency is low, and the existing drugs are highly sensitized, which affects the egg collection efficiency and blastocyst formation rate.
The composition of sodium selenite, vitamin E, arginine hydrochloride and triethyl citrate is prepared by sterile water dissolution, sterilization and freeze-drying, which is used to improve the effect of live egg collection in dairy cows. Reduce sensitization reactions and improve oocyte count and blastocyst formation rate.
It significantly improved the number of follicles, available oocytes and blastocyst formation rate of cows, reduced the sensitization reaction of drugs to animals, and improved the in vitro embryo production efficiency.
Smart Images

Figure CN117017929B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of animal husbandry, and in particular relates to veterinary medicine, and particularly relates to a composition for improving egg collection effect, and a preparation method and application thereof. Background Art
[0002] The statements in this section merely provide background information related to the present invention and do not necessarily constitute prior art.
[0003] The live egg collection and in vitro embryo production technology, which is a combination of technologies such as live egg collection from dairy cows, in vitro maturation of oocytes, in vitro fertilization, embryo culture, embryo freezing, and embryo transplantation, can provide high-quality experimental materials for the application of modern breeding technologies such as embryo engineering and gene editing. It is also an important means to improve breeding efficiency and promote breeding progress. Therefore, the live egg collection and in vitro embryo production technology for dairy cows has received more and more attention. However, the live egg collection and in vitro embryo production technology for dairy cows has not yet been widely applied in my country. The fundamental reason is that the efficiency of in vitro embryo production is low. Therefore, how to improve the efficiency of in vitro embryo production has become a bottleneck restricting the industrial application of the live egg collection and in vitro embryo production technology for dairy cows.
[0004] Live egg collection is the first step in live egg collection-in vitro embryo production, and it is also one of the key links that determine the final production efficiency of this technology. Therefore, how to improve the effect of live egg collection in dairy cows, obtain more and better quality oocytes, and thus obtain more and better quality embryos, has become one of the effective ways to improve the efficiency of in vitro embryo production in dairy cows. In this context, it is necessary to develop a new method or drug to improve the effect of live egg collection in dairy cows and provide more high-quality oocytes for in vitro embryo production.
[0005] Sodium selenite-vitamin E is mainly used to prevent sows from not coming into estrus, piglets from white diarrhea, foot rot and nutritional liver necrosis caused by vitamin E and selenium deficiency in livestock and poultry. It can also enhance the body's immunity, promote growth and improve the meat-to-feed ratio. If used in laying hens and ducks, it can increase egg weight, increase egg production, increase eggshell hardness and reduce breakage rate. Existing data prove that it has the effect of improving reproductive performance. However, there has been no report on whether it can be used to promote ovulation in dairy cows, improve oocyte development and increase blastocyst formation rate.
[0006] In addition, sodium selenite and vitamin E are difficult to dissolve in water and have extremely poor stability. In order to improve their solubility, other compounds are added in the prior art to achieve the purpose. Patent CN 103006692A discloses a sodium selenite vitamin E injection, which uses Tween-80 or polyoxyethylene castor oil EL-40 as a solubilizer to enhance solubility; Patent CN 101982176B discloses a veterinary compound sodium selenite-vitamin E oral nanoemulsion preparation, which still uses Tween-80 or polyoxyethylene castor oil EL-40 to achieve the purpose of enhancing solubility. However, both Tween-80 and polyoxyethylene castor oil EL-40 have strong allergenicity, and even cause inflammatory reactions during animal use, reducing the efficiency of egg collection and thus reducing the blastocyst formation rate. Summary of the invention
[0007] In order to overcome the above-mentioned deficiencies of the prior art, the present invention provides a composition for improving the egg collection effect, and a preparation method and application thereof.
[0008] The present invention uses sodium selenite, vitamin E, arginine hydrochloride and triethyl citrate as raw materials to prepare an injectable drug. Combined with the use method provided by the present invention, the problem of high sensitization of existing drugs is solved, and the present invention can be used to improve the problems of small number of follicles and available oocytes, poor egg collection effect and low blastocyst formation rate in the process of in vitro embryo production of dairy cows.
[0009] To achieve the above objectives, one or more embodiments of the present invention provide the following technical solutions:
[0010] In a first aspect, the present invention provides a composition for improving the effect of egg collection, wherein the composition consists of sodium selenite, vitamin E, arginine hydrochloride, and triethyl citrate.
[0011] In another specific embodiment of the present invention, the mass ratio of sodium selenite, vitamin E, arginine hydrochloride and triethyl citrate is 5:250:100:2.
[0012] In a second aspect, the present invention provides a method for preparing a composition, comprising mixing the composition described in the first aspect in proportion, dissolving the mixture with sterile water, sterilizing the dissolved composition, and freeze-drying the mixture to obtain a sterile composition.
[0013] In another specific embodiment of the present invention, the sterilization method is to use a 0.22 μm microporous filter membrane for filtration sterilization.
[0014] In another specific embodiment of the present invention, the freeze-dried product is in powder form; the powder is packaged into sterile vials for later use.
[0015] In a third aspect, the present invention provides an injection for improving the effect of egg collection, wherein the injection comprises the composition described in the first aspect;
[0016] The injection further comprises a solvent;
[0017] Preferably, the solvent is sterile water.
[0018] In another specific embodiment of the present invention, the final concentration of the sodium selenite is 0.001 g / mL; the final concentration of the vitamin E is 0.05 g / mL.
[0019] In a fourth aspect, the present invention provides use of the composition described in the first aspect or the injection described in the third aspect in the preparation of a product for improving the effect of live egg collection in dairy cows, specifically for improving the blastocyst formation rate.
[0020] In a fifth aspect, the present invention provides a method for improving the effect of egg collection, comprising selecting a donor cow, injecting the composition described in the first aspect or the injection described in the third aspect once every three months before and after egg collection, and then collecting eggs from the donor cow and performing in vitro embryo production.
[0021] In another specific embodiment of the present invention, the donor cow is a healthy dairy cow;
[0022] The period from before egg collection to after egg collection specifically starts from three months before egg collection and ends three months after egg collection stops;
[0023] Preferably, the injection dose is 0.0125 mL / Kg.
[0024] One or more of the above technical solutions have the following beneficial effects:
[0025] Arginine hydrochloride can regulate the growth and development of the body. It is an essential amino acid for the synthesis of proteins in animals and a precursor for the synthesis of various bioactive substances. Arginine helps improve blood circulation in reproductive organs and promotes oocyte development. Arginine hydrochloride can work with sodium selenite and vitamin E to increase the number of ovarian follicles and the quality of oocytes in animals.
[0026] Triethyl citrate can promote the dissolution of sodium selenite and vitamin E, while weakening allergic reactions, reducing the harm of the composition to animals and preventing inflammation caused by allergic reactions, thereby affecting the egg collection effect. Arginine hydrochloride and triethyl citrate can also form a protective layer in the process of preparing freeze-dried powder to prevent the stability of sodium selenite and vitamin E from being destroyed, further improving the activity of the composition.
[0027] Arginine hydrochloride and triethyl citrate can work synergistically with sodium selenite and vitamin E to improve the problems of small number of oocytes, poor egg collection, and low blastocyst formation rate in the process of in vitro embryo production in dairy cows, and effectively reduce the receptor's allergy rate to drugs.
[0028] Based on the composition, injection and use method provided by the present invention, oocytes with higher developmental potential can be obtained each time egg collection is performed, thereby obtaining more transplantable embryos, further improving the efficiency of in vitro embryo production in dairy cows.
[0029] Advantages of additional aspects of the present invention will be given in part in the following description, and in part will become obvious from the following description, or will be learned through practice of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0031] Figure 1 The present invention is a flowchart of processing donor cattle according to an embodiment of the present invention. DETAILED DESCRIPTION
[0032] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0033] It should be noted that the terms used herein are for describing specific embodiments only and are not intended to be limiting of exemplary embodiments according to the present invention.
[0034] In the absence of conflict, the embodiments of the present invention and the features of the embodiments may be combined with each other.
[0035] Embodiment 1
[0036] After measuring the amount of added substances in multiple groups, the inventors finally determined that the mass ratio of sodium selenite, vitamin E, arginine hydrochloride, and triethyl citrate is 5:250:100:2, and the final concentration of sodium selenite is 0.001 g / mL. After a large number of screening experiments, the inventors determined the above optimal ratio.
[0037] Under a sterile environment, take 1g of sodium selenite, 50g of commercially available vitamin E API (>99%), 20g of arginine hydrochloride, and 0.4g of triethyl citrate, dissolve in sterile water, and adjust the volume to 1L. Filter and sterilize with a 0.22μm microporous filter membrane, freeze-dry and dispense into vials, with 0.357g of dried powder dispensed into each vial. When in use, inject 5mL of sterile water into each vial, and the standard for use is 0.0125mL / kg.
[0038] Comparative Example 1
[0039] Under a sterile environment, take 1g of sodium selenite and 50g of commercially available vitamin E raw materials (>99%), dissolve them in sterile water, and adjust the volume to 1L. Filter and sterilize with a 0.22μm microporous filter membrane, freeze-dry and dispense into vials, with 0.255g of dried powder dispensed into each vial. When using, inject 5mL of sterile water into each vial, and the usage standard is 0.0125mL / kg.
[0040] Comparative Example 2
[0041] Under a sterile environment, take 1g of sodium selenite, 50g of commercially available vitamin E API (>99%), and 20g of arginine hydrochloride, dissolve in sterile water, and adjust the volume to 1L. Filter and sterilize with a 0.22μm microporous filter membrane, freeze-dry and dispense into vials, with 0.355g of dried powder dispensed into each vial. When in use, inject 5mL of sterile water into each vial, and the standard for use is 0.0125mL / kg.
[0042] Embodiment 2
[0043] 1. Donor cattle processing
[0044] B-ultrasound is used to monitor the development of follicles on the ovaries of candidate donor cows, and cows with well-developed bilateral ovaries and a total number of follicles greater than 10 are selected as donor cows for processing.
[0045] Three months before egg collection, the donor cattle were intramuscularly injected with the compositions prepared in Example 1, Comparative Example 1 and Comparative Example 2.
[0046] When the composition is used, it is first diluted with injection water to a sodium selenite concentration of 0.001 g / mL and a vitamin E concentration of 0.05 g / mL, and the composition is injected according to the body weight of the cattle.
[0047] 2. Egg collection and in vitro embryo culture: The first live egg collection is performed three months after the day of drug injection. During the egg collection period, the donor cow can be continuously collected eggs, with an interval of once every two weeks. During egg collection, the development of ovarian follicles is observed and recorded. The collected oocytes are fertilized in vitro with frozen semen to produce in vitro embryos.
[0048] 3. Data analysis: When collecting eggs from donor cows, the development of ovarian follicles and the number of available oocytes were counted. The collected oocytes were used to produce in vitro embryos, and the blastocyst formation rate during the culture process and the number of embryos obtained from each live egg collection were counted. The specific results are shown in Table 1.
[0049] Table 1
[0050]
[0051] Note: Different superscript letters indicate significant differences (P<0.05)
[0052] As can be seen from the data in Table 1, the composition provided by the present invention can significantly increase the average number of follicles and the average number of available follicles, the blastocyst formation rate and the number of embryos obtained per egg collection of donor cattle, thereby increasing the number of subsequent embryos and improving production efficiency, indicating that arginine hydrochloride and triethyl citrate can cooperate with sodium selenite and vitamin E to improve the effect of donor cattle egg collection; blastocyst formation rate = number of embryos obtained / number of available oocytes × 100%, the blastocyst formation rate represents the potential for subsequent development of embryos formed by fertilization of oocytes and embryos, and the average number of embryos obtained per egg collection represents the number of embryos obtained by in vitro fertilization and in vitro culture of available oocytes obtained per egg collection. The higher the number of embryos obtained per egg collection, the more products (embryos) are obtained, the higher the production efficiency, and the lower the cost of a single embryo under the same labor, reagent and consumable costs. The data in Table 1 of the present invention show that the composition provided by the present invention improves the blastocyst formation rate while improving the effect of egg collection.
[0053] Embodiment 3
[0054] The intended egg donor cows are Holstein cows, 6-14 months old, empty-breasted, and non-estrus young cows, with no reproductive system diseases after rectal examination.
[0055] Treatment: Three months before egg collection, donor cattle were injected intramuscularly with the composition of Example 1; until three months after egg collection was stopped, the donor cattle were injected with the composition of Example 1 once every three months.
[0056] Injection dose: Each injection dose is 5 mL of a composition having a sodium selenite concentration of 0.001 g / mL and a vitamin E concentration of 0.05 g / mL, that is, the injection dose is 0.05 g of sodium selenite and 0.25 g of vitamin E. A composition comprising sodium selenite and vitamin E.
[0057] Egg collection and in vitro embryo culture: The first egg collection is carried out three months after the injection of the drug. During the egg collection period, the donor cow can be continuously collected with an interval of once every two weeks. The donor cow does not need any pre-treatment. During the egg collection, the development of ovarian follicles is observed and recorded. The collected oocytes are fertilized in vitro with frozen sperm from Holstein bulls to produce in vitro embryos.
[0058] Data analysis: When collecting eggs from donor cows, the development of ovarian follicles was counted. The collected oocytes were used to produce in vitro embryos, and the blastocyst formation rate during the culture process was counted. The specific results are shown in Table 2.
[0059] Embodiment 4
[0060] The intended egg donor cows are Holstein cows, aged 2-6 years old, pregnant cows confirmed to be more than 30 days pregnant, and free of reproductive system diseases after rectal examination.
[0061] Treatment: Three months before egg collection, donor cattle were injected intramuscularly with the composition of Example 1; until three months after egg collection was stopped, the donor cattle were injected with the composition of Example 1 once every three months.
[0062] Injection dose: Each injection dose is 5 mL of a composition with a sodium selenite concentration of 0.001 g / mL and a vitamin E concentration of 0.05 g / mL, that is, the injection dose is 0.05 g of sodium selenite and 0.25 g of vitamin E. The donor cow is injected with a composition containing sodium selenite and vitamin E once every three months until three months after egg collection stops.
[0063] Egg collection and in vitro embryo culture: The first egg collection is carried out three months after the injection of the drug. During the egg collection period, the donor cow can be continuously collected with an interval of once every two weeks. The donor cow does not need any pre-treatment. During the egg collection, the development of ovarian follicles is observed and recorded. The collected oocytes are fertilized in vitro with frozen sperm from Holstein bulls to produce in vitro embryos.
[0064] Data analysis: When collecting eggs from donor cows, the development of ovarian follicles was counted. The collected oocytes were used to produce in vitro embryos, and the blastocyst formation rate during the culture process was counted. The specific results are shown in Table 2.
[0065] Embodiment 5
[0066] The intended egg donor cows are Holstein cows, aged 2-6 years old, empty-stomach cows, and have no reproductive system diseases after rectal examination.
[0067] Treatment: Three months before egg collection, donor cattle were injected intramuscularly with the composition of Example 1; until three months after egg collection was stopped, the donor cattle were injected with the composition of Example 1 once every three months.
[0068] Injection dose: Each injection dose is 5mL of a composition with a sodium selenite concentration of 0.001g / mL and a vitamin E concentration of 0.05g / mL, that is, the injection dose is 0.05g sodium selenite and 0.25g vitamin E. Until three months after the egg collection is stopped, the donor cow is injected with a composition containing sodium selenite and vitamin E every three months. Egg collection and in vitro embryo culture: From the day of drug injection, the first egg collection is carried out three months later. During the egg collection period, the donor cow can be continuously egg-collected, and the egg collection interval is once every two weeks. The donor cow does not undergo any pre-treatment. When collecting eggs, observe and record the development of ovarian follicles. The collected oocytes are fertilized in vitro with frozen sperm from Holstein bulls to produce in vitro embryos.
[0069] Data analysis: When collecting eggs from donor cows, the development of ovarian follicles was counted. The collected oocytes were used to produce in vitro embryos, and the blastocyst formation rate during the culture process was counted. The specific results are shown in Table 3.
[0070] In order to verify the effect of the present invention, a comparative example is set for comparison, as follows:
[0071] Comparative Example 3
[0072] The intended egg donor cows are Holstein cows, 6-14 months old, empty-breasted, and non-estrus young cows, with no reproductive system diseases after rectal examination.
[0073] Treatment: Donor cattle do not undergo any treatment.
[0074] Egg collection and in vitro embryo culture: During normal egg collection, the donor cow can be continuously collected with an interval of once every two weeks, and the donor cow does not need any pre-treatment. During egg collection, the development of ovarian follicles is observed and recorded. The collected oocytes are fertilized in vitro with frozen sperm from Holstein bulls to produce in vitro embryos.
[0075] Data analysis: When collecting eggs from donor cows, the development of ovarian follicles was counted. The collected oocytes were used to produce in vitro embryos, and the blastocyst formation rate during the culture process was counted. The specific results are shown in Table 2.
[0076] Comparative Example 4
[0077] The intended egg donor cows are Holstein cows, aged 2-6 years old, pregnant cows confirmed to be more than 30 days pregnant, and free of reproductive system diseases after rectal examination.
[0078] Treatment: Donor cattle do not undergo any treatment.
[0079] Egg collection and in vitro embryo culture: The first egg collection is carried out three months after the injection of the drug. During the egg collection period, the donor cow can be continuously collected with an interval of once every two weeks. The donor cow does not need any pre-treatment. During the egg collection, the development of ovarian follicles is observed and recorded. The collected oocytes are fertilized in vitro with frozen sperm from Holstein bulls to produce in vitro embryos.
[0080] Data analysis: When collecting eggs from donor cows, the development of ovarian follicles was counted. The collected oocytes were used to produce in vitro embryos, and the blastocyst formation rate during the culture process was counted. The specific results are shown in Table 3.
[0081] Comparative Example 5
[0082] The intended egg donor cows are Holstein cows, aged 2-6 years old, empty-stomach cows, and have no reproductive system diseases after rectal examination.
[0083] Treatment: Donor cattle do not undergo any treatment.
[0084] Egg collection and in vitro embryo culture: The first egg collection is carried out three months after the injection of the drug. During the egg collection period, the donor cow can be continuously collected with an interval of once every two weeks. The donor cow does not need any pre-treatment. During the egg collection, the development of ovarian follicles is observed and recorded. The collected oocytes are fertilized in vitro with frozen sperm from Holstein bulls to produce in vitro embryos.
[0085] Data analysis: When collecting eggs from donor cows, the development of ovarian follicles was counted. The collected oocytes were used to produce in vitro embryos, and the blastocyst formation rate during the culture process was counted. The specific results are shown in Table 4.
[0086] Table 2
[0087]
[0088] Table 3
[0089]
[0090] Table 4
[0091]
[0092] Description of indicators in the table:
[0093] The number of follicles, number of recovered oocytes, number of available oocytes, blastocyst formation rate, and number of embryos obtained per egg collection in Examples 2 to 4 were tested using a t-test.
[0094] As can be seen from the data in Table 2, the number of follicles, the number of available oocytes, the blastocyst rate, and the number of embryos obtained in each egg collection of dairy cows treated with the composition are significantly different (P<0.05). This shows that the composition treatment of Example 2 can improve the oocyte development potential of 6-14 month old, empty-pregnant, and estrus Holstein cows and improve the efficiency of in vitro embryo production in dairy cows.
[0095] As can be seen from the data in Table 3, the number of follicles, the number of available oocytes, the blastocyst rate, and the number of embryos obtained per egg collection of dairy cows treated with the composition are significantly different (P<0.05). The composition treatment of Example 2 can improve the development potential of oocytes in pregnant Holstein cows aged 2-6 years old and confirmed to be pregnant for more than 30 days, and improve the efficiency of in vitro embryo production in dairy cows.
[0096] The data in Table 4 show that the number of follicles, the number of available oocytes, the blastocyst rate, and the number of embryos obtained per egg collection of dairy cows treated with the composition are significantly different (P<0.05). The composition treatment of Example 2 can improve the development potential of oocytes in 2-6 year old Holstein cows and improve the efficiency of in vitro embryo production in dairy cows.
[0097] Although the above describes the specific implementation mode of the present invention in conjunction with the accompanying drawings, it is not intended to limit the scope of protection of the present invention. Those skilled in the art should understand that various modifications or variations that can be made by those skilled in the art on the basis of the technical solution of the present invention without creative work are still within the scope of protection of the present invention.
Claims
1. A composition for improving the effect of egg collection, It is characterized in that The composition consists of sodium selenite, vitamin E, arginine hydrochloride and triethyl citrate.
2. The composition according to claim 1, It is characterized in that The mass ratio of the sodium selenite, vitamin E, arginine hydrochloride and triethyl citrate is 5:250:100:
2.
3. A method for preparing a composition, It is characterized in that The composition of claim 1 is mixed in proportion, dissolved with sterile water, and the dissolved composition is sterilized and freeze-dried to obtain a sterile composition.
4. The preparation method according to claim 3, It is characterized in that The sterilization method is to use a 0.22µm microporous filter membrane for filtration sterilization.
5. The preparation method according to claim 3, It is characterized in that After freeze-drying, it becomes powder; the powder is divided into sterile vials for later use.
6. An injection for improving the effect of egg collection, It is characterized in that The injection comprises the composition according to claim 1 or 2; The injection further includes a solvent.
7. The injection according to claim 6, It is characterized in that The solvent is sterile water.
8. The injection according to claim 6, It is characterized in that The final concentration of the sodium selenite is 0.001 g / mL; the final concentration of the vitamin E is 0.05 g / mL.
9. Use of the composition of claim 1 or the injection of claim 6 in the preparation of a product for improving the effect of live oocyte collection in dairy cows, specifically for improving the blastocyst formation rate.
10. A method for improving the effect of egg collection, It is characterized in that Select a donor cow, inject the composition of claim 1 or the injection of claim 6 once every three months before and after egg collection, then collect eggs from the donor cow and perform in vitro embryo production; The donor cow is a healthy dairy cow; The period from before egg collection to after egg collection specifically starts from three months before egg collection and ends three months after egg collection is stopped.
11. The method for improving egg collection effect according to claim 10, It is characterized in that The injection dose is 0.0125mL / Kg.
